Dr. Angstreich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 Superior Avenue
Suite 300
Newport Beach, CA 92663Phone+1 949-646-6441Fax+1 323-442-5953
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1997 - 2000
- Washington University in St. Louis School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2011 - 2025
- CT State Medical License 2004 - 2011
- MD State Medical License 2001 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Publications & Presentations
PubMed
- 74 citationsEffects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.Greg R. Angstreich, William Matsui, Carol Ann Huff, Milada S. Vala, James Barber
British Journal of Haematology. 2005-08-01 - 23 citationsTreatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant.Greg R. Angstreich, B. Douglas Smith, Richard J. Jones
Current Opinion in Oncology. 2004-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: